Contact
QR code for the current URL

Press release Box-ID: 599813

Eurofins Genomics GmbH Anzinger Str. 7a 85560 Ebersberg, Germany http://www.eurofinsgenomics.com
Contact Ms Dr. Jutta Huber +49 8092 8289930
Company logo of Eurofins Genomics GmbH
Eurofins Genomics GmbH

Eurofins MWG Operon Extends Its Gene Synthesis Business With The Acquisition Of Entelechon

(PresseBox) (Ebersberg, Germany, )
Eurofins MWG Operon, the genomics division of Eurofins Scientific, the global leader in bio-analytical testing, announces the acquisition of Entelechon GmbH. Entelechon is a globally operating provider of gene synthesis, serving the pharmaceutical industry as well as academic and public research institutes.

Founded in 1999 in Regensburg, Germany, Entelechon was one of the first companies specialised in commercial gene synthesis and has focused on advanced genomics and proteomics projects bringing broad experience in the fields of gene optimisation and synthesis.

As part of this transaction, the Entelechon gene synthesis business and the brand "Entelechon" will be integrated into the Eurofins MWG Operon gene synthesis business unit starting from June 1, 2013, resulting in an extremely powerful combined genomic services platform.

"The acquisition through Eurofins should generate considerable synergies and additional value to our customers," says Markus Fischer, Managing Director of Entelechon GmbH who will actively contribute to the integration of Entelechon into Eurofins, while remaining CEO of PolyQuant GmbH, a spin-off of Entelechon involved in protein expression and quantitative proteomics. "In view of gene optimisation, the combined platform GENEius 2.0 of both companies, has become even more effective and powerful than the former individual solutions of each party."

"Entelechon is an excellent strategic fit with Eurofins MWG Operon' genomic service offering and their competence on gene synthesis services and synthetic biology complements our DNA synthesis and sequencing units in an excellent way, while providing us with additional tools to serve the fast growing applied genetics markets", says Bruno Poddevin, Vice President of Eurofins MWG Operon. "The acquisition of Entelechon is a next step to further grow the business and strengthen our position as one of the market leaders in genomic services."

Eurofins Genomics GmbH

Eurofins MWG Operon, a member of the Eurofins Group with major offices and production sites in Europe, the United States and Asia, is an international provider of genomic services established around the core business lines DNA sequencing, oligonucleotides, siRNA and gene synthesis. The company is focussed on high quality services in industrial scale for the life science industries and academic research institutions around the world.

For further information please visit eurofinsgenomics.com.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.